Suberoylanilide Hydroxamic Acid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Suberoylanilide Hydroxamic Acid, covering 2014-05-21 to 2014-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]